Kosala Dissanayake
Lecturer in Veterinary Biomedical Sciences
Contact details
- Tel: +441316506258
- Email: kosala.dissanayake@ed.ac.uk
- Web: Euan MacDonald centre
Address
- Street
-
The Royal (Dick) School of Veterinary Studies
Easter Bush Campus - City
- Midlothian
- Post code
- EH25 9RG
Background
Kosala graduated from university of Peradeniya, Sri Lanka with a degree in veterinary medicine and animal science in 2007. After short time in small animal and exotic animal practice in Sri Lanka, she moved to Scotland to do a masters in integrative neuroscience at university of Edinburgh (2010) before completing her PhD in neuroscience from the same university (2015). Her PhD project was to understand the neuromuscular transmission failure in organophosphorus pesticide toxicity in humans, under the supervision from Prof. Richard Ribchester and Prof. Michael Eddleston. Then she undertook a post-doctoral research project looking at further mechanisms of her PhD research project (2015 – 2020).
Following a brief post-doctoral project with Prof. David Wyllie and Prof. Peter Kind at university of Edinburgh (2021- 2022), Kosala became a lecturer in Veterinary Biomedical Science at the Royal (Dick) School of veterinary studies in 2022.
Her current research focuses are on investigating calcium (Ca²⁺)-induced excitotoxicity at the neuromuscular junction in response to anticholinesterase exposure, with the aim of understanding the underlying mechanisms of neuromuscular dysfunction. A complementary area of her research involves identifying and characterising muscle-derived candidate biomarkers in blood for the diagnosis of amyotrophic lateral sclerosis (ALS) and monitoring disease progression. Ultimately, this work aims to advance our understanding of neuromuscular pathophysiology and contribute to the development of improved diagnostic and disease-monitoring strategies for ALS.
Qualifications
2015 Doctor of Philosophy (PhD). University of Edinburgh
2010 Master of Science (MSc by research). University of Edinburgh
2007 Bachelor of Veterinary medicine and Animal Science (BVSc). University of Peradeniya, Sri Lanka
Responsibilities & affiliations
Animal Body 3 course organiser
Principle investigator - Euan MacDonald Centre for Motor Neurone Disease Reasearch
Undergraduate teaching
Year 1 : Animal body 1
Year 2 : Animal body 3 & Animal Body 4
Year GEP : Animal body
Year 3 - 5 : Student research component
Open to PhD supervision enquiries?
Yes
Current PhD students supervised
Joanna Haley - PhD student
Research summary
1. Synaptic Excitotoxicity and Neuromuscular Junction Vulnerability
Synaptic vulnerability to excitotoxicity may represent a shared mechanism contributing to neurodegeneration in several disorders, including motor neuron disease (MND), amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease and Huntington’s disease. Understanding how excitotoxicity disrupts synaptic function and contributes to neuronal degeneration may help identify therapeutic strategies to slow or prevent disease progression. Calcium (Ca²⁺)-dependent excitotoxicity, which can lead to cellular dysfunction and death, is a proposed mechanism at both glutamatergic and cholinergic synapses.
Our research investigates how excitotoxic stimuli disrupt normal intracellular Ca²⁺ handling, with a particular focus on the neuromuscular junction (NMJ). We aim to determine whether excitotoxic Ca²⁺ elevations arise from excessive Ca²⁺ release from the sarcoplasmic reticulum through ryanodine receptors (Ca²⁺-induced Ca²⁺ release), or from impaired cytoplasmic Ca²⁺ clearance and muscle relaxation due to dysfunction of the sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase (SERCA). Using pharmacological approaches, we investigate the mechanisms underlying fast and slow Ca²⁺ transients and post-tetanic Ca²⁺ elevations, examining the contributions of CaV1.1/dihydropyridine receptors (DHPRs), ryanodine receptors and inositol trisphosphate receptors (IP₃Rs). We also explore whether enhancing Ca²⁺ removal through SERCA, sarcolemmal Ca²⁺ transporters or mitochondrial uptake can reduce pathological Ca²⁺ elevations, and investigate the potential role of magnesium (Mg²⁺) in modulating Ca²⁺-dependent excitotoxicity.
To investigate the relevance of these mechanisms to human disease, we examine post-mortem NMJ tissue from cases of pesticide toxicity, seeking evidence of Ca²⁺-dependent excitotoxicity and synaptic degeneration. This work aims to improve our understanding of how organophosphorus pesticide exposures disrupt neuromuscular function and contribute to synaptic injury.
2. Muscle-Derived Biomarkers for Amyotrophic Lateral Sclerosis
A second major focus of our research is the identification and characterisation of circulating, muscle-derived candidate biomarkers for the diagnosis and monitoring of ALS progression. The considerable heterogeneity of MND, including differences in clinical presentation, disease progression and potential initiating mechanisms, remains a major challenge to understanding disease biology and developing effective treatments.
Progressive muscle weakness is a hallmark of ALS, and abnormalities at the NMJ and within skeletal muscle may emerge early in the disease course, potentially preceding substantial motor neuron loss. As the critical interface between motor neurons and skeletal muscle, the NMJ provides an important site for investigating early disease-related changes. Skeletal muscle may also act as a biological amplifier of molecular and cellular changes associated with denervation, producing alterations in gene expression and other disease-related processes that could be detected in the circulation.
Using animal models of progressive partial skeletal muscle denervation, we investigate muscle-derived molecular signatures and their potential to serve as blood-based biomarkers. Our goal is to identify candidate markers that could support earlier diagnosis, improve the assessment of disease progression and help monitor responses to treatment. Such biomarkers could also contribute to patient stratification, clinical trial design and the development of more personalised approaches to ALS management.
Through these complementary research programmes, our lab aims to uncover mechanisms of synaptic vulnerability, understand the contribution of Ca²⁺ dysregulation to neuromuscular injury, and translate insights into improved diagnostic and therapeutic strategies for neurodegenerative disease.
